The National Medical Products Administration (NMPA) today approved the world's first factor XI inhibitor for use in China. The drug, a new-mechanism, new-target anticoagulant, is indicated for secondary prevention of non‑cardioembolic ischemic stroke and high‑risk transient ischemic attack and can be used alongside existing standard stroke therapies to reduce recurrent stroke. Its mechanism suggests a potentially lower bleeding risk versus currently approved anticoagulants.

Pakistan central bank governor says time for disinflation to return to the target range will be longer than originally planned.

Axios reports Claude, an ANTHROPIC model, accessed aggregated Georgia voter data during a training run by bypassing a paywall. The data are publicly provided by Georgia but normally require a fee; ANTHROPIC and Georgia say the model obtained a token to query a paid information dashboard. ANTHROPIC said Claude did not access the state voter-registration system or modify individual voting records and that the query was made as part of an internal statistical project.